glutamic acid has been researched along with acamprosate in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (23.81) | 18.2507 |
| 2000's | 8 (38.10) | 29.6817 |
| 2010's | 7 (33.33) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Madamba, SG; Schweitzer, P; Siggins, GR; Zieglgänsberger, W | 1 |
| Wickelgren, I | 1 |
| Bolo, N; Dahchour, A; De Witte, P; Durbin, P; Macher, JP; Muzet, M; Nédélec, JF | 2 |
| Dahchour, A; De Witte, P | 1 |
| al Qatari, M; Harris, B; Khan, S; Littleton, J | 1 |
| Ball, D; De Witte, P; Marshall, EJ; Martinez, J; Ward, RJ | 1 |
| Abarca, C; Albrecht, U; Depner, M; Holzberg, D; Lascorz, J; Lathrop, M; Magnone, MC; Matsuda, F; Pendyala, G; Sanchis-Segura, C; Schreiber, S; Schumann, G; Soyka, M; Spanagel, R; Zghoul, T | 1 |
| Buonopane, A; Petrakis, IL | 1 |
| Bochenski, M; Danysz, W; Kotlinska, J | 1 |
| Quertemont, E; Tambour, S | 1 |
| Howland, RH | 1 |
| Atzori, M; Paz, RD; Tardito, S; Tseng, KY | 1 |
| Adams, LJ; Doty, L; George, DT; Heilig, M; Hommer, D; Lifshitz, M; Momenan, R; Schwandt, ML; Shen, J; Singley, E; Spanagel, R; Umhau, JC; Vengeliene, V; Zhang, Y | 1 |
| Choi, DS; Hinton, DJ; Lee, MR; Macura, SI; Mishra, PK; Port, JD; Wu, J | 1 |
| Choi, DS; Frye, MA; Hinton, DJ; Jacobson, TL; Lee, MR; Macura, SI; Mishra, PK; Mrazek, DA | 1 |
| Hirouchi, M; Oka, M; Oyama, T; Sugahara, S; Tamura, M | 1 |
| Biernacka, JM; Choi, DS; Frye, MA; Geske, JR; Hinton, DJ; Ho, AM; Karpyak, VM; Nam, HW; Prieto, ML; Weinshilboum, RM | 1 |
| Cicin-Šain, L; Kovak-Mufić, A; Marušić, S; Matošić, A; Vidrih, B | 1 |
| Biernacka, JM; Choi, DS; Feeder, SE; Frye, MA; Gunderson, LJ; Hinton, DJ; Karpyak, VM; Port, JD | 1 |
| Egerton, A | 1 |
6 review(s) available for glutamic acid and acamprosate
| Article | Year |
|---|---|
Pharmacotherapy of alcohol use disorders.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Amitriptyline; Antidepressive Agents, Tricyclic; Comorbidity; Disulfiram; Dopamine; Drug Interactions; Ethanol; Female; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Male; Mental Disorders; Naltrexone; Narcotics; Serotonin; Taurine | 2005 |
Preclinical and clinical pharmacology of alcohol dependence.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Disulfiram; Dopamine; GABA Modulators; Glutamic Acid; Humans; Naltrexone; Narcotic Antagonists; Serotonin; Taurine | 2007 |
Glutamate-modulating drugs & the treatment of mental disorders.
Topics: Acamprosate; Amantadine; Cycloserine; Glutamic Acid; Humans; Ketamine; Lamotrigine; Memantine; Mental Disorders; Psychotropic Drugs; Riluzole; Taurine; Triazines | 2007 |
Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology.
Topics: Acamprosate; Age of Onset; Antipsychotic Agents; Glutamic Acid; Humans; Neurosciences; Psychopharmacology; Schizophrenia; Schizophrenic Psychology; Synaptic Transmission; Taurine | 2008 |
NEUROBIOLOGICAL BASES OF ALCOHOL ADDICTION.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Brain; Disulfiram; Dopamine; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Minisatellite Repeats; Monoamine Oxidase; Naltrexone; Narcotic Antagonists; Neuropeptide Y; Norepinephrine; Ondansetron; Polymorphism, Genetic; Serotonin; Synaptic Transmission; Taurine | 2016 |
The potential of
Topics: Acamprosate; Alcoholism; Brain; Central Nervous System Agents; Drug Development; Glutamic Acid; Humans; Ketamine; Neuroimaging; Proton Magnetic Resonance Spectroscopy; Reproducibility of Results | 2021 |
2 trial(s) available for glutamic acid and acamprosate
| Article | Year |
|---|---|
Central effects of acamprosate: part 2. Acamprosate modifies the brain in-vivo proton magnetic resonance spectrum in healthy young male volunteers.
Topics: Acamprosate; Adult; Alcohol Deterrents; Aspartic Acid; Brain; Creatine; Cross-Over Studies; Dipeptides; Double-Blind Method; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Phosphocreatine; Taurine | 1998 |
Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study.
Topics: Acamprosate; Adult; Alcohol Deterrents; Alcoholism; Corticotropin-Releasing Hormone; Creatine; Dexamethasone; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Glucocorticoids; Glutamic Acid; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Taurine | 2010 |
13 other study(ies) available for glutamic acid and acamprosate
| Article | Year |
|---|---|
Acamprosate (calcium acetylhomotaurinate) enhances the N-methyl-D-aspartate component of excitatory neurotransmission in rat hippocampal CA1 neurons in vitro.
Topics: Acamprosate; Alcohol Deterrents; Animals; Evoked Potentials; Glutamic Acid; Glycine; Hippocampus; In Vitro Techniques; Male; N-Methylaspartate; Neurons; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission; Taurine | 1996 |
Teaching the brain to take drugs.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Behavior, Addictive; Brain; Cocaine; Cocaine-Related Disorders; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Rats; Receptors, Glutamate; Substance-Related Disorders; Synaptic Transmission; Taurine | 1998 |
Central effects of acamprosate: part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats.
Topics: Acamprosate; Alanine; Alcohol Deterrents; Alcoholism; Animals; Arginine; Aspartic Acid; Chromatography, High Pressure Liquid; gamma-Aminobutyric Acid; Glutamic Acid; Male; Nucleus Accumbens; Rats; Rats, Wistar; Taurine | 1998 |
Acamprosate decreases the hypermotility during repeated ethanol withdrawal.
Topics: Acamprosate; Alcohol Deterrents; Animals; Central Nervous System Depressants; Ethanol; Glutamic Acid; Male; Motor Activity; Nucleus Accumbens; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Taurine | 1999 |
Acamprosate is neuroprotective against glutamate-induced excitotoxicity when enhanced by ethanol withdrawal in neocortical cultures of fetal rat brain.
Topics: Acamprosate; Alcohol Deterrents; Animals; Calcium Radioisotopes; Cell Death; Cells, Cultured; Ethanol; Glutamic Acid; L-Lactate Dehydrogenase; Neocortex; Neuroprotective Agents; Potassium; Rats; Rats, Sprague-Dawley; Taurine | 2001 |
Investigation of the therapeutic efficacy of a taurine analogue during the initial stages of ethanol detoxification: preliminary studies in chronic alcohol abusers.
Topics: Acamprosate; Alcoholism; Amino Acids; Chlordiazepoxide; Chronic Disease; Ethanol; GABA Modulators; Glutamic Acid; Humans; Molecular Structure; Taurine | 2000 |
The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption.
Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Amino Acid Transport System X-AG; Animals; Biological Clocks; Cell Cycle Proteins; Cocaine; Cocaine-Related Disorders; Glutamic Acid; Humans; Mice; Nuclear Proteins; Period Circadian Proteins; Taurine; Time Factors; Transcription Factors | 2005 |
N-methyl-D-aspartate and group I metabotropic glutamate receptors are involved in the expression of ethanol-induced sensitization in mice.
Topics: Acamprosate; Alcoholism; Animals; Brain; Cyclopentanes; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Synergism; Ethanol; Glutamic Acid; Male; Mice; Motor Activity; N-Methylaspartate; Pyridines; Quinolines; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Stereotyped Behavior; Synaptic Transmission; Taurine; Thiazoles | 2006 |
Acamprosate reduces ethanol drinking behaviors and alters the metabolite profile in mice lacking ENT1.
Topics: Acamprosate; Alcohol Drinking; Animals; Equilibrative Nucleoside Transporter 1; Ethanol; Glutamic Acid; Male; Metabolome; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Nucleus Accumbens; Taurine; Up-Regulation | 2011 |
Ethanol withdrawal-induced brain metabolites and the pharmacological effects of acamprosate in mice lacking ENT1.
Topics: Acamprosate; Animals; Brain; Equilibrative Nucleoside Transporter 1; Ethanol; gamma-Aminobutyric Acid; Glutamic Acid; Magnetic Resonance Spectroscopy; Mice; Mice, Knockout; Phosphorylation; Substance Withdrawal Syndrome; Taurine | 2012 |
Acamprosate {monocalcium bis(3-acetamidopropane-1-sulfonate)} reduces ethanol-drinking behavior in rats and glutamate-induced toxicity in ethanol-exposed primary rat cortical neuronal cultures.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Acamprosate; Alcohol Drinking; Animals; Behavior, Animal; Cells, Cultured; Cerebral Cortex; Dizocilpine Maleate; Ethanol; Glutamic Acid; Lactate Dehydrogenases; Male; Neurons; Neuroprotective Agents; Neurotoxins; Nifedipine; Pyridines; Rats; Rats, Wistar; Signal Transduction; Taurine | 2013 |
Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjects.
Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Biomarkers; Glutamic Acid; Humans; Taurine; Treatment Outcome | 2015 |
Anterior Cingulate Glutamate Is Reduced by Acamprosate Treatment in Patients With Alcohol Dependence.
Topics: Acamprosate; Adult; Alcohol Deterrents; Alcoholism; Female; Glutamic Acid; Gyrus Cinguli; Humans; Male; Middle Aged; Proton Magnetic Resonance Spectroscopy; Taurine; Treatment Outcome; Young Adult | 2016 |